# Care Capital

Care Capital is a Private Equity based in Princeton, United States.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Princeton, United States
- **Region:** North America
- **Address:** Princeton, NJ, United States
- **Founded:** 2001
- **Assets under management:** Undisclosed
- **Website:** carecapital.com
- **LinkedIn:** https://www.linkedin.com/company/care-capital

## Regulatory record

- **CRD number:** 312131
- **SEC file number:** 801-128405
- **Registration status:** Registered
- **Reports private funds:** Yes
- **IAPD record:** https://adviserinfo.sec.gov/firm/summary/312131

## About

Care Capital is an SEC-registered investment adviser since 2023. The firm manages approximately $427 million in regulatory assets. It has 7 employees and 7 investment advisers.

## Sectors

- Life Sciences
- Digital Health
- Biotechnology

## Questions

### How does Care Capital source its investment opportunities?

Care Capital's deal flow originates primarily from the professional networks of its partners, most of whom held senior R&D or executive roles at large pharmaceutical companies. The firm evaluates academic spinouts, early-stage biotech platforms, and assets that large pharma companies have strategically deprioritized. This network-driven model leverages decades of relationships across academic medical centers, research institutions, and corporate R&D divisions in the US and Europe.

### How does Care Capital's pharma-operator background influence its investment decisions?

The firm's partners — including founder Jan Leschly and other former Merck and SmithKline Beecham executives — evaluate every asset through a clinical-regulatory lens rather than a purely financial one. Investment committee discussions prioritize target-product profiles, clinical-trial design, and FDA pathway feasibility. This operating DNA means the firm often identifies value in scientifically compelling assets that generalist venture investors lack the expertise to diligence.

### Does Care Capital invest across medical devices in addition to therapeutics?

Yes, the firm's mandate extends to medical devices alongside its core focus on small-molecule therapeutics and biologics. Its partners assess device opportunities with the same regulatory-pathway rigor they apply to drug candidates, though the historical portfolio has weighted more heavily toward pharmaceutical and biologic interventions in CNS, metabolic disease, and oncology.

### What is Care Capital's structure, and what types of LPs invest in the fund?

Care Capital operates as a traditional private equity fund manager with a closed-end fund structure. Its limited partner base has historically included institutional allocators and corporate venture arms from large pharmaceutical companies — a hybrid LP profile that reflects the firm's dual identity as a financial investor and a translational research partner. The firm has not publicly disclosed its total assets under management.

## Related profiles

- [Cardiff Capital Management](https://altss.com/profile/cardiff-capital-management)
- [Caribou Asset Management](https://altss.com/profile/caribou-asset-management)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/care-capital

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology